FDA OKs ADHD Generics; Flotation Therapy; Civilians Respond to Distress Calls

(MedPage Today) -- The FDA approved the first generic forms of lisdexamfetamine dimesylate (Vyvanse) capsules and chewables to treat attention deficit-hyperactivity disorder (ADHD) in patients 6 years and older, as well as moderate to severe binge...
Source: MedPage Today Psychiatry - Category: Psychiatry Source Type: news